Nikko Asset Management Americas, Inc. Crispr Therapeutics Ag Transaction History
Nikko Asset Management Americas, Inc.
- $8.64 Billion
- Q3 2024
A detailed history of Nikko Asset Management Americas, Inc. transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Nikko Asset Management Americas, Inc. holds 2,967,219 shares of CRSP stock, worth $120 Million. This represents 1.61% of its overall portfolio holdings.
Number of Shares
2,967,219
Previous 3,151,514
5.85%
Holding current value
$120 Million
Previous $170 Million
18.09%
% of portfolio
1.61%
Previous 1.99%
Shares
25 transactions
Others Institutions Holding CRSP
# of Institutions
490Shares Held
58MCall Options Held
1.1MPut Options Held
1.9M-
Capital International Investors Los Angeles, CA7.93MShares$321 Million0.07% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl7.5MShares$304 Million3.35% of portfolio
-
State Street Corp Boston, MA2.99MShares$121 Million0.01% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.2.97MShares$120 Million0.1% of portfolio
-
Black Rock Inc. New York, NY2.78MShares$112 Million0.0% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $3.16B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....